Synapse - Radiation Oncology, Department of

Results (5284)

Minimal residual disease (MRD) detection by ctDNA in relation to radiographic disease progression in patients with stage I-III non-small cell lung cancer (NSCLC) treated with definitive radiation therapy

Meeting Abstract

Lebow, E. S.; Murciano-Goroff, Y. R.; Jee, J.; Kalashnikova, E.; Feeney, J.; Sethi, H.; Aleshin, A.; Kris, M. G.; Chaft, J. E.; Rudin, C. M.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Prognostic implications of HER2Neu-low in metastatic breast cancer

Meeting Abstract

Hasan, S.; Neubauer, Z.; Press, R. H.; Chhabra, A.; Fox, J. L.; Cahlon, O.; Bakst, R. L.; Simone, C. B.; Choi, J. I.
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

A pilot study of neoadjuvant cemiplimab with platinum-doublet chemotherapy and cetuximab in patients with resectable, locally advanced head and neck squamous cell carcinoma (HNSCC)

Meeting Abstract

Dunn, L.; Sherman, E. J.; Ho, A. L.; Ganly, I.; Riaz, N.; Morris, L.; Hung, K. W.; Kriplani, A.; Cracchiolo, J. R.; Cohen, M.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Durvalumab (D) and PET-directed chemoradiation (CRT) after induction FOLFOX for esophageal adenocarcinoma: Final results

Meeting Abstract

Cowzer, D.; Wu, A. J. C.; Sihag, S.; Walch, H. S.; Park, B. J.; Jones, D. R.; Gu, P.; Maron, S. B.; Sugarman, R.; Chalasani, S. B.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Single agent PD-1 blockade as curative-intent treatment in mismatch repair deficient locally advanced rectal cancer

Meeting Abstract

Cercek, A.; Lumish, M. A.; Sinopoli, J. C.; Weiss, J. A.; Shia, J.; Stadler, Z. K.; Yaeger, R.; Smith, J. J.; Saltz, L. B.; El Dika, I. H.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

CD19-specific CAR-T cells for the treatment of CNS chloromas in children with relapsed/refractory B-cell acute lymphoblastic leukemia

Meeting Abstract

Shahid, S.; Cancio, M.; Haque, S. S.; Khakoo, Y.; McWilliams, E.; Santomasso, B. D.; Scaradavou, A.; Spitzer, B.; Wolden, S. L.; Boelens, J. J.; more...
Bone Marrow Transplantation (2022)

Fulltext@MSK | Save

Neoadjuvant and adjuvant pembrolizumab plus standard of care (SOC) for the treatment of resectable locally advanced (LA) head and neck squamous cell carcinoma (HNSCC): Phase 3 KEYNOTE-689

Meeting Abstract

Klochikhin, A.; Haddad, R. I.; Meirovitz, A.; Safina, S.; Brana, I.; Le Tourneau, C.; Uppaluri, R.; Lee, N. Y.; Cohen, E. E. W.; Chernock, R.; more...
Asia-Pacific Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

International recommendations for plasma Epstein-Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: Lessons from the COVID-19 pandemic

Review

Lee, V. H. F.; Adham, M.; Ben Kridis, W.; Bossi, P.; Chen, M. Y.; Chitapanarux, I.; Gregoire, V.; Hao, S. P.; Ho, C.; Ho, G. P.; more...
Lancet Oncology (2022)

Fulltext@MSK | Save

Final analysis of consolidative use of radiotherapy to block (CURB) oligoprogression trial - A randomized study of stereotactic body radiotherapy for oligoprogressive metastatic lung and breast cancers

Meeting Abstract

Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Eng, J.; Yeh, R.; Girshman, J.; Das, J.; Gelblum, D.; Xu, A. J.; more...
International Journal of Radiation Oncology, Biology, Physics (2022)

Fulltext@MSK | Save

NRG/RTOG 1112: Randomized phase III study of sorafenib vs. stereotactic body radiation therapy (SBRT) followed by sorafenib in hepatocellular carcinoma (HCC) (NCT01730937)

Meeting Abstract

Dawson, L. A.; Winter, K.; Knox, J.; Zhu, A. X.; Krishnan, S.; Guha, C.; Kachnic, L. A.; Gillin, M. T.; Hong, T. S.; Craig, T.; more...
International Journal of Radiation Oncology, Biology, Physics (2022)

Fulltext@MSK | Save